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Introduction 
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Introduction 
 
 
 
 Various dentofacial deformities are corrected by orthognathic surgical 
procedures,  which  lead to significant blood loss due to soft tissue and 
intrabony bleeding from medium sized vessels to capillaries.  Most of the 
bleeding cannot be controlled by usual surgical techniques employed in soft 
tissue surgery like identification and ligation of vessels.  In this situation 
induced hypotensive anesthesia appears as an ideal method to decrease the 
blood loss and amount of transfusions following orthognathic surgery.  The 
whole blood loss is decreased by more than 40% during hypotensive 
anesthesia as compared with normotensive anesthesia for similar orthognathic 
surgical procedures.  Dropping  the mean arterial pressure from preoperative 
level of 90mm of Hg to intraoperative level of 60mm of Hg effects this 
reduction in blood loss.  It was decided to conduct a randomized, prospective 
clinical study to determine the efficacy of hypotensive anesthesia in 
minimizing blood loss during orthognathic surgery. 
 
Deliberate Hypotension: 
 Deliberate or controlled hypotension is an anesthetic technique that 
permits the clinician to lower arterial pressure effectively in order to decrease 
blood loss during surgery and to provide a blood less field for the surgeon. 
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The main purpose of deliberate hypotension is to decrease blood loss, 
thereby decreasing the need for blood transfusion and, or improving 
operating conditions at the surgical site.  The latter, namely improved 
visibility for the surgeon to perform more delicate surgical procedures.  The 
bleeding could be controlled not only by  a reduction in blood pressure,  but 
by proper positioning  of the patient as well.  Since that time, deliberate 
hypotension has often been controversial, primarily because of  inability to 
define the lowest safe arterial pressure with confidence.  Such terms as 
"Controlled hypotension", "induced hypotension", "deliberate hypotension" 
and "hypotensive anesthesia" have all been used. 
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Review of Literature 
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Review of Literature 
 
 Controlled hypotension has been changing continuously and evolving 
not only as the result of the discovery of new agents and techniques, but also 
from an improved understanding of the underlying physiological changes 
which accompany its practice.  Almost without exception, the techniques and 
agents used  for controlled hypotension have arisen from an "accidental" 
finding. 
 
 DAVY (1800) 10  gave an enigmatic statement in the history of 
anesthesia stating if nitrous oxide is used with advantage during surgical 
operations there was no great effusion of blood. 
 
 In a few short years following a Second World War anesthesia took a 
second leap forward after a century of relative quiescence 
 
 KING (1934) 39 studied  the activity  of certain compounds which arose 
from the discovery of the quaternary nitrogen atoms in the structure of 
tubocurarine. 
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MINITT and GILLIES (1944) 50 showed that anesthesia was 
maintained with chloroform, cyclopropane or sometimes trichloroethelene 
together with nitrous oxide and oxygen. 
 
GARDNER (1946) 22 described about hemorrhage and hypotension as 
a technique to control it. 
 
GRIFFITHS and GILLIES (1948) 26 described hypotension by giving a 
high spinal block and showed a decrease in blood loss. 
 
PATON and ZAIMIS (1948a) 56 set out to explore the tubocurrarine 
like action of polymethelene, bis-quaternary ammonium salts. 
 
PATON and ZAIMIS (1948a) 56 wrote on the clinical potentialities of 
two members of the series of compounds namely hexamethonium and 
decamethonium. 
 
HUNTER (1950) 34 considered hexamethonium as a more effective 
antidote than pentamenthonium. 
DAVISON (1950) 9 and ORGANE (1950) 54 were deliberately 
lowering  arterial pressure during anesthesia at New Castle and West Minister 
hospital, to reduce blood loss intraoperatively. 
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SCURR (1951) 66  introduced suxamethonium into clinical practice 
 
GRAY and REES (1952) 25 used muscle relaxants and caused 
deliberate paralysis with artificial ventilation via an endotracheal tube.  These 
caused narcosis, relaxation and reflex suppression. 
 
WYMAN (1953) 81 gave details, based on a series of 1000 major 
surgical cases in which induced hypotension has been used. 
 
ENDERBY (1953) 18 introduced pentolinium, a ganglionic blocking 
agent, which is short acting and to be given by infusion and thus permitting a 
new dimension in controllability which has been surpassed only by sodium  
nitroprusside. 
 
MORACA  et al (1962) 51 quoted that neurosurgical practice has an 
obvious requirement for  a technique of extreme evanescence and for this 
reason introduced sodium nitroprusside into clinical practice, which caused 
hypotension intraoperatively. 
 
ECKENHOFF et al (1963)13 demonstrated enormous dead space 
during induced hypotension and most authorities advocate controlled 
ventilation to ensure adequate alveolar ventilation. 
 15
ECKENHOFF et al (1964) 14 did a comparative study on two groups 
one with hypotension and the other with normotension and found that 
deliberate hypotension did not lead to changes in mental function as 
measured by psychological tests. 
 
GILLIES and HOLMES  (1965) 23 with reference to the triad's 
approach explained that venous congestion associated with respiratory 
obstruction and the cardiovascular effects of carbon dioxide retention are the 
commonest causes of abnormal ozzing and hypotension is necessary to 
prevent these effects. 
 
BROWN and HORTON (1966) 6 described a technique in which a 
cardiac pacemaker electrode was used to pace the heart so rapidly that stroke 
volume was extremely curtailed however, this had limited application. 
 
SCURR (1971) 67 quoted that death from anesthesia passed its zenith in 
spite of an increase in the number of administrations. 
 
ROLLASON, W.N. et al (1971) 64  did a comparative study of mental 
function in relation to hypotensive and normotensive anesthesia in the elderly 
and concluded that both groups of patients were equally at risk. 
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PRYS – ROBERTS et al (1972) 60 predicted the decrease in cardiac 
output associated with most techniques expect nitroprusside administration  
and the severe depressant effect of high doses of halothane on the 
myocardium was appreciated.  
 
 BLACKBURN et al (1973) 4 stressed the role of posture and an  
increased airway pressure in relation to pharmacological blockade during 
anesthesia.  
 
 HARP J. R and WOLLAMN H (1973) 30 explained the compensatory 
mechanism that tends to prevent cerebral hypoxia during controlled 
hypotension.  
 
 ECKENHOFF and LEIGH (1974) 15 demonstrated that adequate 
alveolar ventilation in induced hypotension is a must but without 
hyperventilation. 
 
 GRIFFITHS D.P.G et al (1974) 27 did a study of cerebral blood flow 
and metabolism during hypotension induced with sodium nitroprusside and 
found out that there were no complications that be attributed to sodium 
nitroprusside. 
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 LINDOP (1975) 44 stated that controlled hypotension and shock have in 
common a low arterial pressure, and since the latter may be fatal and 
instinctive reaction, has always been that deliberate hypotension must of it 
self increase morbidity and mortaliy over non hypotensive techniques for the 
same surgical procedure. 
 
 
* THOMPSON G. et al (1978) 75  previous study of blood loss and 
organ functions to determine the effect of induced hypotension 
postoperatively on brain, liver and kidney function and found that there was 
no morbidity and this procedure shortened the operating time, decreased 
blood loss and decreased the number of blood transfusions. 
 
 BEHNIA R. et al M.D (1978) 1 did a study on sodium nitroprusside 
induced hypotension and its effect on renal function and found out that 
medullary renal tissue oxygenation, and index of tissue viability, may remain 
adequate, despite a significant decrease in endogenous creatinine clearance 
during hypotension procedure.  
 
* FAHMY N.R M.D (1978) 21 did a comparative study on 
nitroglycerine and nitroprusside and found out that nitroglycerine is an 
effective hypotensive drug that is proved superior as it is safe and does not  
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cause any myocardial infarction, renal damage, or cerebral vascular 
complications. 
 
 MURALI SIVARAJAN. M.D et al (1980) 52 did a study on what 
determines the blood loss during induced hypotension and found out that 
operative blood loss during induced hypotension is determined by mean 
arterial pressure and not cardiac output. 
 
 Chamberlain J.H et al (1980) 7 compared drug induced hypotension 
between halothane and nitroprusside and hypotension on myocardial 
metabolism and concluded that reduction in mean arterial pressure to those 
levels by either method is not likely to impair myocardial energetics in 
healthy hearts with normal coronary anatomy. 
 
 NORLEN K (1988) 53 did a study on central and regional 
hemodynamics during controlled hypotension produced by adenosine, 
nitroprusside, nitroglycerine and found out that urine flow was greatly 
impaired during the infusion of adenosine. 
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 LESSARD M.R. et al (1989) 43 did a study on isoflurane-induced 
hypotension in orthonathic surgery and found out that isoflurane effectively 
reduced blood loss and the number of transfusions in orthognathic surgery. 
 
 YOSHITO SHIRAIHI et al (1994) 82 did a study on controlled 
hypotension and oxygen uptake and carbon dioxide elimination and found out 
that the balance between them and demand of oxygen supply was maintained 
during induced hypotension with PGE1 or nitroglycerine. 
 
 PRECIOUS D. et al (1996) 58 compared blood loss, quality of surgical  
Field, and duration of procedure with and without induced hypotension 
anesthesia in adolescent orthognathic surgery patients and concluded that 
induced hypotensive anesthesia results in both reduced blood loss and 
improvement in surgical field. 
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Materials and methods 
 
 
 
 After obtaining approval from the patient and the parents, 6 patients 
within the age group of years 21-34 were studied in a prospective, 
randomized, stratified and single blind fashion. 
 
 The patients were randomly allotted to A or B group.  "A" group is a 
normotensive group (normal) on whom a routine anesthetic procedure, is to 
be adopted. "B" group is a hypotension group on whom hypotensive 
anesthesia is to be adopted. 
 
 The patients selected for study were those  requiring orthognathic 
procedures, for either single or both the jaws.  All patients were healthy ASA 
class I subjects.  The ASA class includes: 
 Class I: Healthy patient  
 Class II: Mild systemic disease – no functional limitation. 
 Class III: Severe systemic disease a – definite functional limitation. 
 Class IV: Severe systemic disease a  that is constant threat of life.  
Class V: Moribund patient not expected to survive 24 hrs with or  
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  without operation.  
(a – Whether or not the systemic disease is the disease for which a 
patient is undergoing surgery.) 
 
Patients belonging to ASA II-IV were not included in the study.  In 
particular asthmatic patients were strictly excluded.  Preoperative 
investigations included hemoglobin percentage, packed cell volume, 
urinenalysis, urea and creatinine.  The patient's baseline blood pressure was 
recorded.  
 
 
Method of general anesthesia 
 
Premedication:  All the patients included in the study were given the 
following pre-medications: 
 
 8 Hours before surgery ---- Tab-Diazepam --------- 10mg 
               Tab-Ranitidine --------- 150mg 
         Tab-Metaclopromide --- 10mg 
 1 hour before surgery ------  Inj – Glycopyrrolate ----- 0.2mg I.M. 
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Preparation: 
 
 Two good venous accesses one of the infusion of hypotensive agents 
and the other for the fluid administration were gained. Inj – Cephatxim 1gm 
and Metronidazole 1gm were given as a routine prophylactic antibiotic.  Inj – 
Dexamethasone 8mg was given as a routine.  Bladder was catheterized with 
Folley's catheter to monitor hourly urine output. 
 
 The patients were connected to the monitors like continuous ECG> 
SpO2, Pulse rate. Respiratory rate and non-invasive blood pressure.  The 
alarms were selected and entered into the monitor. 
 
 250ml of 5% dextrose was infused before induction. 
 
 
 
 
 
 
 
 24
 
 
 
 
 
 
 
 
 
 
Procedure 
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Procedure 
 The patient's surgical plan was determined, and a general pre – 
operative assessment was carried out before the surgical procedure.  The 
patients included in the study were pre-medicated.  The pre-operative blood 
pressure was recorded before the patient was shifted to the theatre. 
 
Induction: 
 
 Anesthesia was induced with 5mg/kg of Thiopentone Sodium and Inj- 
Tramadol 2mg/kg was  used as an analgesic agent for both the groups. 
 
Intubation: 
 
 In patients with a normal predicted airway Vercuronium Bromide 
0.05mg/kg were used as a muscle relaxant to facilitate the naso-endotracheal 
intubation.  In patients with a predicted abnormal airway Inj. Succinylcholine 
was used as a muscle relaxant at 2mg/kg dose.  The same method was 
adopted in both the groups. 
Position: 
 Both the group patients after intubation were positioned in (100 Fowler 
position with a sandbag in the inter-scapular region. 
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Maintenance of Anesthesia: 
 In B group patients anesthesia was maintained with 70% of nitrous 
oxide, 30% of oxygen and 1% of halothane.  Holothane was slowly weaned 
off and stopped at the time of would closure,  In 'A' – normotensive group of 
patients halothane of 0.5% was used for the initial hour and stopped. 
 
A) Hypotensive agents: Used on B group – hypotensive patients. 
1) Nitroglycerine - 50mg in  500ml normal saline was infused 
Through a volumetric infusion pump (Figure-1)  just before the 
Induction and this NTG was titrated to keep the mean arterial 
pressures  in between 60 -65mm of  
 
 
 
Figure  - I 
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2) Esmolol was used to prevent the tachycardia response by the 
nitroglycerine.  Esmolol was started at 300 micrograms/kg as a 
bolus followed by an infusion rate to keep the heart rate less than 
100 / min.  This esmolol was infused in a syringe infusion pump 
(Figure-II) 
 
 
Figure - II 
B) Anesthetic agents: 
  In patients of both the groups 
 1) Vercuronium Bromide. a non-depolarizing muscle relaxant was used 
  to  maintain the muscle relaxation. 
2) Tramadol was toped up at 1mg/kg dose if the surgery was prolonged  
 For more than three hours. 
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C) Hypotensive level 
 
 The mean arterial pressure was maintained in between 60-65mm of Hg 
throughout the procedure until the surgeon fixed up the osteotomy segments. 
In case of reduced urine output of less than 0.5ml/kg/hr in spite of adequate 
fluid replacement, the mean arterial pressure was slowly raised roughly by 
around 10mm of Hg to retain the urine output.  At the end of the segmental 
fixation, by reducing the NTG infusion rate to the pre operative value, the 
mean arterial pressure was slowly raised and the hemostasis checked. 
 
D) Fluid management: 
 
 A strict fluid replacement protocol was followed.  Ringer's lactate was 
infused intra-operatively at the rate of 6ml/kg/hr, with a volumertric pump to 
maintain routine intra-operative fluid requirements.  Allowable blood loss 
(ABL)  was defined as 20% of estimated blood volume (male 80ml/Kg, 
female 70ml/Kg).  Blood loss upto the ABL replaced with 3ml of Ringer's 
lactate for each milliliter of blood loss. When blood losses reached the ABL, 
one unit of blood was transfused and then additional unit for every 400 ml of 
blood loss. 
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Monitoring: 
 It includes a non-invasive blood pressure monitor (Figure-III), E.C.G., 
Pulse oximeter and urinary output.  Blood pressure both systolic, diastolic 
and mean arterial pressure, heart rate,  SpO2 were checked and recorded 
every fifteen minutes.  Urine output was measured every hour. 
 
 
Figure - III 
 Before the incision, the surgeon infiltrated the oral mucosa with 2% 
lignocaine with adrenaline 1:80000. 
 
 The duration of the anesthesia, from anesthetic induction to the 
reversal of muscle relaxant's effect was recorded.  The time from first 
incision to the completion of the last suture placement was recorded  as the 
surgical time.  During the procedure, the amount of irrigation fluid was 
precisely measured. 
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Pharmacodynamics 
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PHARMACOKINETICS AND PHARMACODYNAMICS 
Pharmacology of the hypotensive anesthetic drugs: 
 
 The drugs,  used in deliberate hypotension, are: 
 
1. Inhaled anesthetics      - Halothane 
2. Intravenous anesthetics  -  Nitroglycerinee 
    - Esmolol 
Halothane: 
  
Chemical and Physical properties: 
 
 
 Halothane (fluothane) is 2-bromo-2chloro-1, 1-trifluoroethane. 
  
Mixtures of halothane with air or oxygen are not flammable or explosive. 
 
 
 With the exception of chromium, nickel, and titanium, most metals are 
tarnished or corroded by halothane.  The compound interacts with rubber and 
some plastics, but not with polyethylene. 
 
 The solubility of halothane in rubber can theoretically slow the 
induction and the emergence from anesthesia as a consequence of  the uptake 
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or release of the anesthetic from the rubber elements in the anesthesia circuit 
when low flow techniques are used. 
The structure of halothane is : 
   F   Br 
  
  F C   C H 
 
   F   Cl 
 
Pharmacological properties:   
  
 It is a potent anesthetic agent with properties that allow a smooth and 
rather rapid loss of consciousness that progresses to anesthesia.  However, the 
rapidity, convenience, and pleasantness associated with intravenous 
administration of thiopental are usually preferred for induction of anesthesia; 
halothane is then introduced for maintenance of anesthesia during the surgical 
procedure.  The circumstances and requirements of the surgical procedure 
determine whether the trachea is intubated; whether the patient is allowed to 
breathe spontaneously or is ventilated manually or mechanically; and whether 
additional drugs, such as muscle relaxants or analgesics, are administered. 
 The signs of depth of anesthesia with halothane that are most practical 
value are the blood pressure, which is progressively depressed, and the 
response to surgical stimulation (e.g: pulse rate, blood pressure, movement or  
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even awakening).  The concentration of anesthetic agent that is necessary in 
the inspired gas mixture for induction of anesthesia must be appropriately 
reduced as an alveolar concentration increases during maintenance if 
progressive increase in depth of anesthesia and decrease in blood pressure are 
to be avoided. 
 
Circulation: 
 Administration of halothane is characterized by a dose dependent 
reduction of arterial blood pressure.  Hypotension results from two main 
effects.  First, the myocardium is depressed directly and cardiac output is 
decreased; second, the normal baroreceptor-mediated tachycardia in response 
to hypotension is obtunded. 
 
Heart: 
Then anesthesia is induced by inspiration of halothane at 
concentrations commonly necessary for surgical anesthesia (0.8 to 1.2%), 
cardiac output is reduced by 20 to 50% from the level characteristic of the 
awake state (Marshall et al 1969) 46.  Both increased concentrations of 
halothane and reduced arterial carbon dioxide tension (hyperventilation) 
accentuate the reduction in cardiac output. 
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The contractility of preparations of heart muscles in vitro is depressed 
by halothane in a dose dependent fashion.  It is also generally agreed that 
myocardial contractility is reduced during halothane anesthesia (Sonntag et al 
1978)71.  However, after 2 to 5 hours of constant halothane anesthesia all the 
cardiovascular changes (i.e., hypotension, depressed cardiac output, and 
bradycardia) tend to return toward normal; this response has been attributed 
to sympathetic activation with time (Eger et al 1970)16. 
 
Cardiac rhythm: 
 The heart rate is slow during anesthesia with halothane.  This is, in 
part, reversible by atropine and is due to reduction of cardiac sympathetic 
activity with consequent vagal predominance.  However, direct, atropine-
insensitive slowing of SA nodal discharge can be observed in vitro; both a 
reduced rate of phase-4 depolarization and an increased threshold for the 
generation of an action potential appear to be involved.  During halothane 
anesthesia, vagal activity is further enhanced by manipulation of the airway. 
 
 Halothane may also increase the automaticity of the myocardium; this 
effect is aggregated by adrenergic agonists and leads to propagated impulses 
from ectopic sites within the atria or ventricles. 
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Baroreceptor control: 
 Although early work demonstrated that halothane reduces afferent 
discharge by "resetting" the baroreceptors to respond around a lower "set 
point", depresses the vasomotor responds of the brainstem, and reduces the 
sympathetic outflow that results, the observed changes are small.  In addition, 
halothane has little effect on the response of preganglionic symphathetic 
neurons to stimulation of baroreceptors (skovsted et al., 1969)70.  Thus, it is 
concluded that the predominant actions of halothane are at the effector sites 
in the heart that controls cardiac rate and or contractility. 
Organ Blood Flow: 
Halothane influences the blood flow to every organ by both  direct and 
indirect actions (Seyde and Longnecker, 1984) 68.  These include interference 
with the generation or action of factors derived from endothelium that 
regulate the tone of vascular smooth muscles (Stone and Johns,1989) 72.  In 
the skin and cerebral circulation, flow may increase as the vessels dilate.  
However, the cerebrovascular bed, as well as the renal and splanchnic 
circulations, loses some of its ability to autoregulate flow, and perfusion of 
these tissues decreases if blood pressure falls excessively.  The coronary 
circulation remains responsive to myocardial needs for oxygen; vasodilation  
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occurs in poorly ventilated areas of the lung because of inhibition of 
pulmonary vasoconstriction that normally occurs in response to hypoxia. 
In an individual patient, pH and carbon dioxide tension, posture, 
temperature, age, disease, and the administration of other drugs can influence 
blood flow to each of these organs. 
 
Respiration: 
 
 If the patient anesthetized with halothane is allowed to breathe 
spontaneously, an increased partial pressure of carbon dioxide in the arterial 
blood is common and is indicative of ventilatory depression; there is also an 
increased difference between the partial pressure of oxygen in the alveolar 
gas and in the arterial blood, indicating less efficient exchange of gas.  
Halothane thus influences both ventilatory control and the efficiency of 
oxygen transfer.  To compensate for these effects, ventilation is frequently 
assisted or controlled by manual or mechanical means, and the concentration 
of inspired oxygen is increased. 
  Ventilatory Control: 
 Characteristically respirations are rapid and shallow during halothane 
anesthesia.  Minute volume is reduced, and arterial carbon dioxide tension is 
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increased from 40mm of Hg to approximately 50mm of Hg.  Halothane 
causes a dose related reduction in the ventilatory response to carbon dioxide 
(Knill and Gelb,1978) 40. 
 
Pulmonary Oxygen Transfer: 
 Efficient transfer of oxygen from the alveolar gas to hemoglobin in the 
alveolar capillary red blood cell depends on a proper balance between 
alveolar ventilation and perfusion.  This balance is importantly conrolled by 
the effects of gravity and various structural mechanical factors, and fine 
adjustments are provided by changes in the tone of the smooth muscle of 
bronchial airways and pulmonary vessels.  All these factors may be altered 
during halothane anesthesia. 
 
Nervous System: 
 Electrical activity of the cerebral cortex recorded by a frontooccipital 
EEG shows progressive replacement of fast, low voltage activity by slow 
waves of greater amplitude as halothane anesthesia is deepened.  Surgical 
stimulation may reverse this pattern, and such arousal reactions may be 
associated with recall of intraoperative events by patients, as in a dream 
(Bimar and Bellville,1977) 3.This sequence resembles arousal of the brain by 
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activation of brainstem reticular formation, but reticular neuronal activity is  
depressed by halothane (Shimoji et al., 1977) 69. 
 Since cerebral blood flow generally increases during halothane 
anesthesia, cerebrospinal fluid pressure increases (Lassen  and Christensen, 
1976)41. Halothane may thus aggravate conditions in which intracranial 
pressure is elevated.  The cerebral metabolic consumption of oxygen is 
reduced and the delivery of oxygen and substrates to the brain appears to be 
adequate, but there are marked regional differences (Eintrei et al., 1985)17.  
After several hours of anesthesia with halothane the changes in the cerebral 
blood flow and metabolism return toward normal (Warner et al., 1985)77. 
 Recovery of mental function after even brief anesthesia with halothane 
is not complete for several hours, but this phenomenon probably contributes 
little to the more prolonged impairment of psychological performance that 
has been reported after major surgery.  Shivering during recovery is common 
and probably represents both a response to heat loss and an ill-defined 
expression of neurological recovery. 
Muscle:  
Relaxation of skeletal muscle is desirable or necessary for many 
surgical procedures.  Anesthesia with halothane causes some relaxation by 
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central depression; in addition, the duration and magnitude of the muscular 
relaxation induced by non-depolarizing skeletal muscle relaxants such as 
tubocurarine or pancuronium are increased.  The mechanism of this effect is 
not known but appears to be based on increased sensitivity of the end-plate to 
the action of the competitive neuromuscular blocking agents (Waund,1977)78. 
  
Rarely, induction of anesthesia with halothane or any of other 
halogenated inhalational anesthetics triggers an uncontrolled hypermetabolic 
reaction in the skeletal muscle of susceptible patients. Rapid rise in the body  
temperature and a massive increase in oxygen consumption and production of 
carbon dioxide characterize the resultant syndrome of malignant 
hyperthermia; death may result unless the anesthetic is discontinued and 
treatment with dantrolene is begun promptly.  This syndrome may be caused 
by a defect in the uptake of Ca2+ by the sarcoplasmic reticulum in genetically 
susceptible muscle(Gronert,1980) 28. 
  
Uterine smooth muscle is relaxed by halothane.  This effect is of 
sufficient magnitude to allow manipulation of fetus during the pre natal 
period.  Inhibition of natural or induced uterine contractions by halothane 
during parturition may prolong the process of delivery, as well as increase 
blood loss. 
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Kidney: 
 Halothane causes dose dependent reductions of renal blood flow and 
the rate of glomerular filteration; these parameters may be 40 to 50% of 
normal at 1 MAC (Mazze et al., 1963)47.  Preoperative hydration and 
prevention of hypontension can attenuate these effects.  Halothane does not 
interfere greatly with autoregulation of renal blood flow nor, in the 
normotensive state, with the distribution of flow between the renal cortex and 
medulla (Leighton and Bruce, 1975)42.  Anesthesia is normally accompanied 
by the production of a small volume of concentrated urine.  The changes in 
urine volume are probably secondary to circulatory responses and reduced 
glomerular filteration (Deutsch et al., 1966)11.  The renal effects of halothane 
anesthesia are rapidly reversed, and there is no evidence of postoperatively 
results in hyponatremia, reduced plasma osmolality, and mental confusion. 
 
Liver and Gastrointestinal Tract: 
  
Splanchnic and, therefore, hepatic blood flow is reduced by halothane 
as a passive consequence of reduced perfusion pressure, but there is no 
evidence of overt ischemia (Epstein et al., 1966 20; Seyde and Longnecker,  
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1984)68. Hepatic cellular functions are, however, depressed, and halothane 
reduces the ability of the microsomal enzymes systems to metabolize drugs. 
Bio-transformation: 
 Approximately 60 to 80% of absorbed halothane is eliminated 
unchanged in the exhaled gas in the first 24 hours after its administration, and 
smaller amounts continue to be exhaled for several days or even weeks.  Of 
the fraction not exhaled, as much as 50% undergoes bio-transformation, and 
the  rest is eliminated unchanged by other routes. 
  
The mixed function oxidase or cytochrome P450 system in the 
endoplasmic reticulum of the hepatocyte is responsible for this bio-
transformation.  Chlorine and to a lesser extent bromine are removed from 
halothane; since the bond energy for C-F is nearly twice that for C-Br of    C-
Cl, little fluorine is removed 24. 
Advantages: 
A. Halothane is non inflammable and does not irritate the respiratory  
Passage.  It has a fruity odour and is not unpleasant for induction. 
B. Induction of anesthesia and recovery are reasonably quick.  The  
               incidence of postoperative vomiting is low. 
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C. Halothane inhibits laryngeal and pharyngeal reflexes in upper            
planes of surgical anesthesia to a considerable extent. It also relaxes 
the masseter muscles and inhibits salivation; hence tracheal 
intubation is much easier with this agent. It does not cause 
laryngospasm, bronchospasm, coughing, but produces 
bronchodilation by a direct relaxation of the bronchial smooth 
muscle.  Hence it is preferred in-patients with history of bronchial 
asthma.  
D. Halothane may be employed to induce control hypotension to 
provide a "bloodless" field during surgery but is safe in expert 
hands with Boyles anesthetic apparatus (Figure-IV).                   
 
 
 
   Figure - IV 
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Disadvantages: 
A. Muscular relaxation with halothane alone is inadequate to permit the 
surgical procedures; however, it potentiates the actions of d-
tubocurarine, includeing its ganglionic blocking effect and this may 
lead to profound hypotension during anesthesia. 
B. It depresses respiration if its concentration in the anesthetic vapour is 
allowed to exceed 2%. 
C. It causes cardiovascular depression and hence, hypotension is a major 
drawback with halothane anesthesia.  It exerts direct depresant action 
on the heart, decreases the cardiac output, reduces the sympathetic 
outflow and increases the parasympathetic tone. The total peripheral 
resistance changes very little even when hypotension occurs.  With 
increased concentration it causes bradycardia. With rapid inhalation or 
a sudden increase in the concentration of halothane, the blood pressure 
may decrease suddenly and cardiac arrest may supervene. 
 
Halothane sensitizes the ventricular muscle and conduction tissue to 
sadrenaline.  It may increase automaticity of the myocardium and may 
cause arrhythmias; usually, these are benign. 
D. Recovery of mental function after halothane takes several hours. 
Shivering during recovery is common.       
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E. Hepatic damage including extensive hepatocellular necrosis, due to 
allergy or idiosyncrasy.  Individuals with hepatic disease and pregnant 
women are more likely to develop severe hepatotoxicity.  Halothane 
should not be repeated at intervals of less than 3 months to avoid liver 
toxicity and should be avoided during pregnancy. 
F.  Halothane is a poor analgesic and must be supplemented with nitrous 
oxide or opiates to provide satisfactory conditions for operation. 
G. Halothane causes rise in intracranial pressure due to cerebral 
vasodilation; hence, it is contraindicated in-patients with intracranial 
lesions65. 
 
Intravenous Anesthetics: 
The intravenous anesthetics are: 
1. Nitroglycerine 
2. Esmolol. 
 
1. Nitroglycerine: 
The drug has been used for years to treat patient's coronary artery 
spasm or with myocardial infractions and to control periods of 
hypertension in-patients with known coronary artery disease. 
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Chemical name of nitroglycerine is 1.2.3 propanetriol trinitrate.  The 
chemical structures of nitroglycerine are: 
 H2C- O -NO2 
 HC- O -NO2 
 H2C- O -NO2 
 
Properties: 
 Nitroglycerine is basically a vascular smooth, muscular relaxant.  It 
dilates both arterial and venous beds, however, it has preferential effect on 
the post capillary vessels, including large veins to which  it promotes 
peripheral pooling of blood and decreasing venous return to the heart leading 
to the reduction of left ventricular end diastolic volume (pre-load).  Arterial 
relaxation produced by nitroglycerine leads to reduction in systemic vascular 
resistance and arterial pressure (after load).  These effects of nitroglycerine 
produce reduction in the myocardial oxygen consumption or demand and thus 
a more favorable supply-demand ratio is achieved. 
  
The recommended doses of intra venous nitroglycerine reduce systolic, 
diastolic and mean arterial pressure while maintaining effective coronary 
perfusion pressure, unless there is an excessive pain in blood pressure. 
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Intra venous nitroglycerine therapy reduces elevated central venous 
and pulmonary capillary wedge pressures, pulmonary vascular resistance and 
systemic vascular resistance.  Heart rate is usually slightly increased, as a part 
of the reflex response to the fall in blood pressure.  Cardiac index may be 
increased, decreased or unchanged.  In the presence of elevated left 
ventricular filling pressure and systemic vascular resistance along with a 
depressed cardiac index there is a likelihood of an improvement in cardiac 
index.  On the other hand, when filling pressures and cardiac index are 
normal, cardiac index may be slightly reduced by intra venous nitroglycerine 
therapy. 
 
Pharmacokinetics: 
 Nitroglycerine is widely distributed in the body and is rapidly 
metabolized to dinitrates and mononitrates.  It has a short half-life, estimated 
of 1 to 4 minutes.  This makes it possible to monitor and control the plasma 
levels of nitroglycerine during intra venous infusion. 
  
Nitroglycerine is readily absorbed into the plastic materials parenteral 
solution containers and tubings of intra venous infusion sets.  Therefore, the 
dilation and storage of nitroglycerine for intra venous infusion should be 
made only in glass parenteral solution bottles. 
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Forty percent to eighty percent of the total amount of nitroglycerine in 
the final diluted solution for infusion is absorbed by the polyvinyl chloride 
(PVC) tubing of the intra venous administration sets.  The rate of absorption 
depends upon the flow rate, nitroglycerine concentration and the length of the 
tubing, etc.,. 
 
Indications: 
1. Angina pectoris, including unstable, angina pectoris and post-infraction 
angina pectoris in-patients who have responded to recommended doses 
of organic nitrates and or beta-blockers. 
2. Acute myocardial infraction, congestion heart failure and improvement 
of coronary circulation opening of collaterals and reduction of infract 
size. 
3. Control of blood pressure in perioperative hypertension i.e., 
hypertension associated with surgical procedures, especially 
cardiovascular procedures, such as hypertension seen during 
intratracheal intubation, anesthesia; skin incision, stemotomy, cardiac 
bypass and in the immediate post-surgical period. 
4. Production of controlled hypotension during procedures. 
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Contraindications: 
1. Known hypersensitivity to nitroglycerine or other organic nitrates. 
2. Hypotension   or   uncovered  hypovolaemia  as  the   use  of   
nitroglycerine injection in such conditions could produce severe 
hypotension or shock. 
3. Increased intracranial pressure (e.g: head     trauma     or   cerebral 
hemorrhage. 
4. Inadequate cerebral circulation, constrictive pericarditis and cardiac 
tamponade. 
 
Precautions: 
 
1. Nitroglycerine injection should be used with caution in-patients     with 
severe hepatic or renal disease. 
2. Excessive fall in blood pressure, especially for prolonged periods of   
time, must be avoided because of possible deleterious effects on the 
brain, heart, liver and kidney from poor perfusion and the attendant 
risks of ischaemia, thrombosis and altered functions of these organs.  
Patients with normal or low pulmonary capillary wedge pressure are 
especially sensitive to the hypotensive effects of nitroglycerine 
injection.  It is advisable to monitor the pulmonary  
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capillary wedge pressure to titrate the dosage of the drug and as it 
generally precedes the occurrence of arterial hypotension. 
3. Use during pregnancy: The safety of the use  of nitroglycerine injection 
during pregnancy has not been established, therefore it should be given 
to pregnant women only if clearly needed. 
 
Adverse effects: 
  
The commonly observed adverse effects of nitroglycerine injection are 
extensions of its pharmacological actions, which include headache, flushing, 
tachycardia, palpitations, retrosternal discomfort and dizziness.  Nausea, 
vomiting and abdominal pain have also been reported.  Paradoxial                
bradycardia and increased angina pectoris may accompany nitroglycerine- 
induced hypotension. 
 
Dosage and administration: 
  
Nitroglycerine injection is a concentrated, potent drug, which must be 
diluted in 5% dextrose or normal saline prior to its infusion.  It should not be 
admixed with other drugs. 
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The administration of nitroglycerine infusion is initially begun with 5 
microgram per minute with subsequent titration to adjust that dose in 
accordance with the clinical situations with increments of 5 microgram per 
minute, every 3 to 5 minutes until some response is noted.  If no response is 
seen at 20 microgram per minute, increments of 10 and later 20 microgram 
per minute can be used.  Once a partial blood pressure response is observed, 
the dose increase should be reduced and the interval between increments 
should be lengthened. 
 
Esmolol: 
 Esmolol is selective β1 antagonist with a very short duration of action.  
It has little if any intrinsic sympathomimetic activity and it lacks membrane 
stabilizing actions. Esmolol is administered intravenously and is used when β 
blockade of short duration is desired or in critically ill patients in whom 
adverse effects of bradycardia, heart failure, or hypotension may necessitate 
rapid withdrawal of drug. 
 
Absorption,fate and excretion: 
 Esmolol has a half-life of about 8 minute and an apparent volume of 
distribution of approximately 2 litres/Kg. The drug contains an ester linkage, 
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and it is hydrolyzed by esterases in erythrocytes.  The half-life of carboxylic 
acid metabolic of esmolol is far longer (4 hours), and it accumulates during 
prolonged infusion of esmolol.  However, this metabolite has very low 
potency as a β-adrenergic antagonist (Reynolds et al., 1986)63; it is excreted 
in the urine. 
  
The onset and offset of β-adrenergic blockade with esmolol are rapid; 
peak hemodynamic effects occur within 6 to 10 min of administration of a 
loading dose, and there is substantial attenuation of β blockade within 20 
minutes of stopping an infusion.  Esmolol may have striking hypotensive the 
effects in normal subjects, although the mechanism is uncertain (Reilly et al., 
1985)61. 
 
Preparations, Routes of Administration and Dosage: 
 Esmolol hydrochloride is available in a concentrated solution (250 
mg/ml) to be diluted prior to use, or in a solution (10 mg/ml) for intravenous 
administration.  To initiate treatment, a loading dose of  500 µg/kg is infused 
over 1 minute; this is followed by infusion of 50 µg /kg / minute for 4  
minutes. If an adequate therapeutic effects is not observed within 5 minutes, 
the same loading dose is repeated and maintenance infusion is increased to 
100µg /kg/minute. The titration can be repeated with progressively greater 4- 
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Minute infusions.  As the desired endpoint is approached, the loading dose is 
omitted and the increment in the maintenance infusion is made more 
gradually.  Responses to esmolol usually occur with maintenance rates above 
50 to 200µg  /  kg  /minute; the safety of maintenance rates above                 
300µg/ kg /minute is not  known.  Infusions  have  been  tolerated  for  up  to   
48 hours. 
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Effect of hypotension on organ function 
 
 
 Deliberate hypotension decreases arterial pressure; it provides the 
surgeon with a dry field and decreases the need for blood transfusion the 
mechanism responsible for the decrease in arterial blood pressure are diverse 
and exert different influences on the various organs of the body.  Obviously 
deliberate hypotension is designed to decrease arterial blood pressure while 
preserving organ blood flow and thereby preserving organ function. It must 
be emphasized that decreasing blood pressure by hemorrhage diminishes 
organ blood flow.  A deliberate hypotension technique requires that 
intravascular fluid volume be constantly judged throughout the surgical 
procedure so as to ensure optimal organ function. 
 
 The effects of hypotension on various organ beds are complex, 
depending on the drugs used and the magnitude and duration hypotension. 
Skin and Muscle: 
 
 Hoffman et al 33., found that in rats blood flow to skin decreased with 
sodium nitroprusside, nitroglycerine, and 2% enflurane while skeletal blood 
flow increased.Wild smith et al79., studied 20 patients undergoing middle ear 
surgery who received either sodium nitroprusside or trimethaphan to induce 
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hypotension. These workers found no change in lactate, pyruvate,or standard 
bicarbonate with either drug.  Extensive clinical experience with a variety of  
drug without evidence of myoglobinuria, skin necrosis, or muscle weakness 
would support the claim that deliberate hypotension is not injurious to these 
tissues.  However, Hauss et al31., found that in the dog, skeletal muscle PO2 
was markedly lowered by sodium nitroprusside and not by nitroglycerine.  
These investigators suggested that the autoregulation of the microcirculation 
is severely impaired with nitroprusside but not with nitroglycerine. 
  
Endrich et al 19., compared the effects of nitroprusside and 
nitroglycerine on striated muscles of hamsters. They not only examined tissue 
oxygenation but also measured microvascular pressures, vascular diameters, 
and density, and blood cell velocity and directly visualized the 
microvasculature.  Significant differences between the two agents were seen.  
Both agents affected resistance vessels similarly, but post-capillaries dilated in 
response to nitroglycerine.  Tissue oxygenation was decreased by sodium 
nitroprusside but not by nitroglycerine.  They concluded that nitroglycerine 
may have a distinct advantage over sodium nitroprusside.  Unfortunately, the 
desired degree of hypotension with nitroglycerine cannot always be achieved. 
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Central Nervous System: 
 
 When deliberate hypotension is used, the main concerned is whether 
cerebral perfusion is adequate.  Adequacy of cerebral blood flow suring 
controlled hypotension has been assessed by the following methods. 
a. Level of consciousness 
b. Jugular bulb venous oxygen tension. 
c. Electroencephalography (E.E.G) 
d. Higher cerebral function after surgery  
e. Cases with cerebral damage after operation 
f. Bichemical indices 
g. Radioactive xenon clearance. 
 
The current rationale for the safe lower limit of mean arterial blood 
pressure of 50 to 55 mm of Hg in normothermic patients is based on the 
concept that the lower limit of autoregulation for cerebral blood flow is at this 
range.  Michenfelder and Theye 49 saw clear neurologic deflicits in two of 5 
dogs anesthetized with nitrous oxide and subjected to 1 hour of hypotension at 
a mean arterial pressure of 40-mm Hg by trimethaphan. Dong et al., 12 
demonstrated that in dogs , there was a poor correlation between EEG and 
brain function.  They subjected dogs to profound hypotension with 
trimethaphan for one hour.  One half the animals died, but this was due to  
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myocardial and liver damage, whereas the surviving animals showed no 
neurologic changes.  Pinaud et al 57., recently studied 9 adult patients 
undergoing for repair of cerebral aneurysms.  Mean arterial pressure was lower 
to 40 mm of Hg with sodium nitroprusside.  Intraoperative cerebral blood flow 
and cerebral metabolic rate for oxygen were measured before, during, and after 
hypotension.  They concluded that this reduction of mean arterial pressure was 
apparently safe for the reason of the brain  studied.  In poorly perfused regions, 
local brain and cerebrospinal fluid lactoacidosis occurring especially in the 
retracted areas might cause at these low pressures, but the study technique did 
not allowq for such a determination. 
 Ishikawa and McDowall 35 examined the affects of nitroprusside and 
trimethaphan in cats subjected to mean arterial pressures of 30,35and 40 mm 
Hg.  Their data demonstrated that cerebral blood flow was significantly greater 
with sodium nitroprusside than with trimenthaphan. 
 Cerebral blood flow appears to be maintained at adequate rates to supply 
the needs for the brain at a mean arterial blood pressure of 50 to 65 mm Hg.  
Grubb and Raichle 29 found that cerebral blood flow is actually increased with 
sodium nitroprusside and reasoned that it might be due to stimulation of the 
sympathetic nervous system with release of circulatory catecholamines.  
Adeeper levels of hypotension with sodium nitroprusside may be preferable. 
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Other hand cerebral perfusion, the effect of drugs on intracranial 
pressure is also of concern, especially in-patients with elevated intracranial 
pressure. In examination the influence of trimethaphan induced hypotension in 
cats, Stulken and Sokoll 73 found significant increases in intracranial pressure 
as compared with hypotension induced by sodium nitroprusside.                   
Subsequently, several investigators found that nitroglycerine , sodium 
nitroprusside and verapamil allincreased intracranial pressure.  Thus, these 
drugs should not be used until the cranium is opened in a patient with 
suspected increased intracranial pressure.  If the measurement of intracranial 
pressure is available before the surgical procedure, titration of drug before the 
opening of the skull seems justified. 
Eye: 
 
  The intraocular pressure of the eye is due to blood and aqueous humor.  
With a reduction in arterial blood pressure, intraocular pressure decreases.  The 
eye has two separate systems of blood vessels, the retinal and uveal.  The uveal 
vessels are peculiar in that they possess no precapillary sphincters, hence a 
steady blood flow.  Since the uveal systems carries the major blood pressure 
are transmitted to the eye with a resultant decrease in intraocular pressure.  
Because of the effect of hypotension on blood flow to the eye, some 
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of the complications of deliberate hypotension are blurring of vision and  
rarely blindness. 
 
Heart:  
 
  The severe depression of the myocardium caused by deep halothane 
anesthesia was a major factor in the development of intravenous hypotensive 
agents.  A wealth of information comparing the effects of nitroprusside, 
nitroglycerine, and trimethaphan used to treat hypertension intraoperatively.  
Only a few studies have examined the effects of these agents on the 
myocardium when mean arterial blood pressure has been decreased to 50 to 65 
mm Hg.  Vance et al 76., suggested that during hypotension induced by 
nitroprusside,  coronary blood flow is well maintained.  Jupa et al 36., compared  
sodium  nitroprusside  and  trimethaphan  and  demonstrated  that auto- 
regulation of coronary blood flow was better maintained with sodium 
nitroprusside.  For example, some patients such as those undergoing clipping 
of the cerebral aneurysm , may require hypotension to help in the surgical 
procedure.  These same patients may also have underlying coronary artery 
disease.  Therefore, knowledge of the use of these drugs during deliberate 
hypotension is important. 
 
 Hickey et al 32., examined the effects of deliberate hypotension in a dog 
model with a single coronary artery stenosis.  Hypotension was induced with  
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trimethaphan, halothane, or sodium nitroprusside to a MAP of 50 mm Hg.  In 
the normal portions of the myocardium, trimethaphan and halothane 
significantly reduced subendocardial and subepicardial blood flow.  A similar 
reduction in myocardial oxygen consumption occurred for each agent.  This 
suggests that coronary blood flow is dependent on myocardial metabolic 
demands.  By contrast, sodium nitroprusside did not affect regional coronary 
blood flow or myocardial oxygen consumption.  With a critical stenosis, 
hypotension with all drugs resulted in reduced regional myocardial blood  
flow and a lowered perfusion pressure.  However, myocardial ischemia did    
not occur.  Lactate extraction continued and no changes in St segments and no 
redistribution of transmural blood flow were found.  With several stenosis, 
deliberate hypotension reduced perfusion pressure, depressed ST segments, 
and produced evidence of ischemia.  The date suggested that trimethaphan was 
the least injurious, but the number animals studied was small.  It should be 
emphasized that this was a dog model and that the stenosis involved only one 
vessel; this is not the common clinical  finding in humans.  Whether these 
findings apply to the patient with stenosis of several coronary arteries has not 
been investigated. 
 The use of isoflurane with or without other hypotensive agents has 
gained popularity.  Decrease in mean arterial pressure to 50 to 60 mm Hg or 
primarily due to decrease in systemic resistance with minimal effects on 
cardiac output.  Priebe 59 has shown, however, that there is some degree of 
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myocardial depression at 1.8% inspired isoflurane in dogs.  This study 
demonstrated a dose dependent decrease in systemic vascular resistance and an 
even greater decrease in coronary vascular resistance.  
 
 Manninen et al 45., studied 33 neurosurgical patients in whom 
hypotension to 50 mm Hg was achieved by using isoflurane anesthesia.  
Although they found that over 50% of the patients developed nonspecific ECG 
changes, there was no evidence of myocardial infraction when cardiac 
enzymes were examined. 
 Reiz et al 62., first suggested that the coronary vasodilation seen with 
isoflurane may not necessarily be beneficial.  The concept that such 
vasodilation could lead to regional myocardial ischemia was referred to as 
"coronary steal."  
 
 Adenosine is also a potent coronary dilator.  Bloor et al 5 ., compared 
adenosine to sodium nitroprusside in 12 normal dogs.  They found that a 50% 
reduction in mean arterial pressure by either agent resulted in morbid 
differences.  Adenosine resulted in a marked increase in coronary blood flow, 
no increase in plasma catecholamines, and no change in cardiac lactic acid 
uptake.  In contrast, sodium nitroprusside resulted in an increase in heart rate 
and plasma catecholamines with evidence of lactic acid production.  Coronary 
sinus blood flow did not increase.  Owell et al 55., administered adenosine to  
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five neurosurgical patients and found significant increase in coronary blood 
flow together with decreases in myocardial oxygen consumption.  They also 
found that the hypotension was easily controlled, probably because of 
inhibition of both the sympathoadrenal and the renin-angiotensin systems.  
Presently, with the limited data available, adenosine can be safely used in-
patients without coronary artery disease.  The potential benefits of adenosine 
in-patients with coronary disease must be tested clinically. 
 
Lungs: 
 
 Eckenhoff et al 13., noted a higher than normal carbon dioxide tension in 
the blood during deliberate hypotension using either pentolinium or 
trimethaphan.  In measuring physiologic dead space in 25 patients, they 
concluded that hypotension combined with increased mean airway pressure, 
head-up tilt, and surgery all may lead to increased dead space.  Khambatta et 
al., 38 measured dead space in-patients undergoing hypotensive anesthesia  with 
sodium nitroprusside.  They concluded that if cardiac output was maintained 
by replacement of intravascular fluids when hypotension was induced, there 
was no increase in physiologic dead space.  This is supported by the findings 
of Suwa et al 74., who demonstrated that a decrease in cardiac output would 
result in an increase in dead space; this may explain the       findings reported 
by Echenhoff et al 13 . 
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 Oxygenation during deliberate hypotension may also be altered.  
Wildsmith et al 80., demonstrated a marked decrease in arterial oxygenation   of 
sodium nitroprusside.  In-patients with chronic obstructive pulmonary disease 
(COPD) in whom the shunt fraction was already increased, no change in shunt 
fraction could be demonstrated.  Nitroglycerine infused both in normal patients 
and in those with COPD responded in a manner similar to  that found with 
sodium nitroprusside.  Bernard et al 2., studied 16 patients undergoing total hip 
arthoplasty.  Deliberate hypotension was induced with either sodium 
nitroprusside or isoflurane.  Pulmonary shunt fraction increased with sodium 
nitroprusside but not with isoflurane. 
 
 Other effects of hypotensive agents on pulmonary function are   
minimal.  The trimethaphan also causes a slight increase in respiratory rate as 
well as slight alveolar hyperventilation.  Lung mechanics was unchanged.  
Because of changes in oxygenation and possibly carbon dioxide elimination, 
controlled ventilation is preferred for patients undergoing deliberate 
hypotension. 
 
Kidneys: 
 Although renal blood flow is decreased, untoward effects are not 
evident.  Behnia et al 1., examined the effect of sodium nitroprusside on 
humans.  Arterial blood pressure was reduced to 50 mm Hg and creatinine   
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clearance determined.  Mannitol, 1 to 1.5gm/kg, was infused to maintain urine  
flow at 1 to 2ml during in the entire procedure.  Creatinine sclearance 
decreased significantly only during the period of hypotension but rapidly 
return to control when arterial blood pressure returned to normal.  In 
trimethaphan, urine flow was maintained greater than 2ml/minute by the 
infusion of 5% dextrose in lactated Ringer's solution at 10ml/kg/hour.  These 
studies also showed a transient decrease in renal function during the period   of 
hypotension. 
 Dong et al 12., found no increase in blood urea nitrogen (BUN) is 
creatinine in dogs subjected to severe hypotension.  Thompson et al 75., could 
find no significant changes in serum creatinine, BUN, serum or urinary 
electrolytes in 30 patients having deliberate hypotension.  Since renal    
dysfunction is not a frequent complication of deliberate hypotension, short 
periods of decreased renal flow apparently are not detrimental. 
Splanchnic circulation: 
 One of the most difficult areas to monitor clinically is the liver 
circulation, as portal venous circulation has no significant autoregulation and 
hepatic autoregulation is minimal.  Thus liver damage could be severe during 
deliberate hypotension.  With MABP of 12 to 25mm Hg during  trimethaphan 
induced hypotension, severe disturbances in liver enzymes result, and 
hepatocyte degeneration and areas appear with pericentral lobular mecrosis. 
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When lesser degrees of hypotension are employed, a mild elevation in 
bromsulfalien retention was noted.  Other tests of liver function showed no 
significant changes.  
 
 The effect of isoflurane on the splanchnic circulation is complex, 
Conzen et al., 8 studied liver blood flow and oxygen tensions in the liver of  
dogs anesthetized with isoflurane.  With increasing amounts of isoflurane there 
was a dose dependent decrease in liver blood flow because of a decrease in 
portal flow.  Splanchnic oxygen consumption remained unchanged.  This 
resulted in a significant decrease in hepatic surface oxygen tension. 
Complications: 
 
Surgical Comomplications: Reactive hemorrhage 
 
 Cut vessels may not bleed during intraoperative hypotension.  When  the 
arterial pressure increase after operation, bleeding may begin.   Reactionary 
hemorrhage and hematoma function have not been a problem,     as bleeding 
can usually be prevented simply by the application of pressure dressings, and 
by the avoidance of sudden return to higher pressures      following surgery. 
 Stasis is not associated with low pressures produced by vasodilating    
techniques.  There is no evidence that the incidence of venous thrombosis is   
increased. 
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Collection of Data 
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DATA COLLECTION 
 
 Preoperatively the gauze was cut into pieces of 4X6 inches and the 
weight of each gauze was determined(Fig.V). The length  and weight of throat 
pack gauze (Roller gauze) was measured.  The number of gauzes used for the 
surgery and the total weight of the gauze was determined, by using the 
common balance.  All the gauzes were sterilized after measuring. 
 
 
 
Figure - V 
 
A total number of 40 gauzes were prepared for every surgery and the 
weight of 40 gauzes were noted.  For every 15 minutes the surgeon Fromme's 
 ordinal scale assessed the surgical field. 
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1)By the surgeon's comment based on Fromme's Ordinal Scale of            
Assessment of Surgical Field is as follows. 
5-Massive uncontrollable bleeding 
4-Bleeding, heavy but controllable, that significantly interfered with the 
dissection. 
3-Moderate bleeding that moderately compromised surgical            
dissection. 
2-Moderate bleeding, a nuisance but without interference with   accurate 
dissection. 
1-Bleeding, so mild that it was not even a surgical nuisance. 
0-No bleeding, virtually bloodless field. 
All these readings were recorded for every 15 minutes.  After the   
surgery was completed, the volume of fluid in the suction apparatus was 
measured (Fig.VI).  The number and the weight of the used gauze were   
measured postoperatively using common balance and also the weight of  
unused gauze was measured. 
 
Figure - VI 
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The blood loss was assessed by 
 
a) Calculating the difference in weight of the gauze, both pre and        Post-
operatively(Fig.VII). 
 
 
 
 
Figure – VII 
 
 
 
b) Suction bottle volume minus irrigation fluid volume. 
 
At the end of the surgery, all the patients were kept in the recovery      room 
until fully awake and then shifted to the ward.  Postoperative I V fluids were 
given depending upon the patient's weight and requirement.  Urea, creatinine, 
serum bilirubin, Hb% and packed cell volume were done on the Ist 
postoperative day to know about the organ function. 
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Proforma 
 70
 
PROFORMA 
       DATE: 
NAME: 
AGE: 
SEX: 
O.P.NO: 
PROCEDURE PLANNED: 
 
 
PRE-OPERATIVE ASSESMENT: 
 
 
Exclusion criteria (ASA-1,patients only are accepted for the study) 
 
1.Cardiac disease 
2.Bronchial asthma (Allergic-cannot use β-blockers) 
3. Hypertension 
4. Pre-op hypotension 
5. Liver dysfunction 
6. Renal dysfunction 
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PRE-MEDICATION: 
 
PRE-OPERATIVE B.P: 
 
PRE-OPERATIVE HB%:  POST-OPERATIVE HB%: 
 
INTRA-OPERATIVE MONITORING: 
 
  STARTING TIME   FINISHING TIME 
 
SURGERY  
 
ANESTHESIA 
 
ANESTHESIA DRUGS USED: 
1. 
2. 
3. 
4. 
5. 
6. 
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7. 
BLOOD LOSS ASSESSMENT 
 
Amount of saline used (Total for irrigation) 
 
 
Volume collected in the suction apparatus: 
 
 
No.of small gauze used: 
 
 
No. of large gauze used (Throat pack): 
 
Fluids given intra-venously at O.T: 
 
Estimation of blood loss by surgeon: 
 
Estimation of blood loss by anesthetist: 
 
 
Total blood loss: 
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ASSESMENT CHART 
 
BLOOD PRESSURE 
TIME 
 
SYSTOLIC 
 
DIASTOLIC 
 
MEAN 
 
HEART 
RATE 
 
 
SPO2 
 
PROCE - 
  DURE 
 
 
 
DRUG 
  ADMINISTERED 
 
FLUID 
ADMINISTERED 
S
US
IRRI
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NORMAL  GROUP 
 
 
 
S.N AG   SEX  LENGTH OF
SURGERY 
LENGTH OF 
ANESTHESIA  
EBL BY 
SURGEON
EBL BY 
ANESTHETIST
1 24 Fem 2Hrs. 2Hrs 15 mts. 900ml 1000ml 
2 21 Fem 2Hrs. 30 mts. 2Hrs 45 mts. 700ml 800ml 
3 34 Fem 2Hrs. 20 mts. 2Hrs 40 mts. 700ml 800ml 
 
 
 
Table – 1 showing age,  sex, length of surgery,  length of anesthesia, estimated blood 
loss by surgeon and anesthetist in control group 
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HYPOTENSION GROUP 
 
 
 
S.N AG   SEX  LENGTH OF
SURGERY 
LENGTH OF 
ANESTHESIA  
EBL BY 
SURGEON
EBL BY 
ANESTHETIST
1 22 Male3 Hrs. 30 mts. 3Hrs. 40 mts. 600 ml 575ml 
2 22 Fem 2 Hrs. 30 mts. 2Hrs. 40 mts. 200 ml 150ml 
3 25 Fem 2 Hrs. 45 mts. 3Hrs. . 500 ml 545ml 
 
 
  
Table – II showing age,  sex, length of surgery,  length of anesthesia, estimated blood 
loss by surgeon and anesthetist in  
   hypertension group 
 
 
 
 
 
 
 
 
 
 
 
\ 
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NORMAL GROUP 
 
 
 
S.No. 15 min 30 min 45 min 1 hr 1hr 15min 1hr 30 min 1 hr 45 min 2 hrs 2hr15m 2hr30m 2hr45m 3 hrs
1 1 1 2 1 1 3 1 0     
2 1 1 2 3 2 1 1 1 1 0   
3 1  1  3  2  1  1  1 1  0    
 
 
 
 
  Table – III showing the scoring of the surgical field according to 
Fromme's ordinal scale in the control group. 
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HYPOTENSION GROUP 
 
 
 
 
 
 
 
S.No. 15 min 30 min 45 min 1 hr 1hr 15min 1hr 30 min 1 hr 45 min 2 hrs 2hr15m 2hr30m 2hr45m 3 hrs
1 1 1 0 0 1 0 0 1 0 0 0 0 
2 1 1  0 0 0 1 0 0 0 1   
3 1 1 0 0 0 0 1 0 0 0 1  
 
 
 
  Table – III showing the scoring of the surgical field according to 
Fromme's ordinal scale in the Hypotensive group. 
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TABLE – V  
VARIABLES AGE 
 
MEAN 
 
S.D 
 
 
CONTROL  
26.3 
 
 
5.26 
 
HYPOTENSION 
 
 
23.30 
 
1.552 
 
Table – V shows that the age distribution among the patients it reveals that  
the mean age is 26.30 with a standard deviation of 5.26 in the control group.  
In the hypotension group the mean age is 23.3 with a standard deviation of 
1.55  This figure explains there is no difference between the ages for the 
control and hypotension group. 
TABLE VI:  
CONTROL HYPOTENSION SEX 
 
 
 
No 
 
% 
 
No 
 
% 
Male 0 0 1 33 
Female 3 100 2 66 
 
Table VI shows that sex distribution among the patients.  The Chi-Squared 
Value is 0.22.  There is no association between the control and hypotension 
group With their sex. 
64 
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TABLE VII: 
 
 
 
CONTROL 
 
HYPOTENSION 
 
t-VAUE 
 
 
VARIABLES 
 
MEAN 
 
S.D 
 
MEAN 
 
S.D 
 
(P-VALUE) 
 
EBL by 
Surgeon 
 
 
733 
 
57.37 
 
433.3 
 
207.99 
 
t.2.406 
p<0.07 
 
EBL by  
Anesthetist 
 
    
866 
 
122.61 
 
423 
 
427.87 
 
t.1.74 
p<0.16 
  
  
A comparison of estimated blood loss (EBL) by the surgeon and 
anesthetist between control and hypotension group.  The statistical analysis of 
the data by student t-test explained that there is a significant difference of 
EBL by surgeon and anesthetist between hypotension and control group at 
P<0.16 level.  The mean values of EBL by surgeon and EBL by anesthetist in 
hypotension group were then compared with control group.  
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EBL by Surgeon  EBL by Anesthetist  
       
 
 
Fig. VIII  is explain that the estimated blood loss by surgeon and 
Anesthetist shows the better values in hypotension anesthesia 
 
 
 
 
 
 
 
 
 
            
 
                         866 
 
 
 
    733 
 
 
       433.3            423 
         
     Control  Hypotensive 
FIGUREVIII : COMPARISON OF ESTIMATED BLOOD 
LOSS BY SURGEON AND ANESTHETIST BETWEEN 
HYPOTENSION AND CONTROL GROUP 
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TABLE VIII: 
 
 
 
  
 
GROUP 
 
MEAN 
 
S.D 
 
 
Control 
 
1.25 
 
0.04 
 
 
Hypotension 
 
0.37 
 
0.02 
 
t- Value 32.869 
(p<0.001) 
 
 
 
 
 
 Table VIII shows that the assessment of hypotension and control 
Group, the student t-test value is 32.869.  It reveals that there is statistically 
Significant difference between hypotension and control group at p<0.001 
Level.  The assessment of the surgical field by surgeon reveals that the 
hypotension group is better than the control  group. 
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PHOTOGRAPHS 
 
A. NORMAL  
 
1.  NAME:  MISS. VIDHYA, 21/FEMALE, I.P. No.84451 
Le Fort I  Osteotomy 
 
PREOPERATIVE      POSTOPERATIVE 
 
                      
 
2.  NAME:  MISS. NIRANJANI, 24/FEMALE, I.P. No.11561 
 Anterior Maxillary Osteotomy 
  
PREOPERATIVE      POSTOPERATIVE 
 
             
 
 
3. NAME: Mrs. RANI, 34/FEMALE, I.P. No. 74822 
 Anterior Maxillary Osteotomy 
  
PREOPERATIVE      POSTOPERATIVE 
 
                              
                                                                                            
PHOTOGRAPHS 
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B. HYPOTENSION 
 
1.  NAME:  Mr. RAJA, 22/MALE, I.P. No. 58497 
Le Fort I  Osteotomy 
 
PREOPERATIVE       POSTOPERATIVE 
                     
 
2. NAME: MISS. RUKMANI, 20/FEMALE, I.P.No.90029 
 Anterior Maxillary Osteotomy 
  
PREOPERATIVE      POSTOPERATIVE 
 
                       
 
3. NAME: MISS. KAVITHA, 25/FEMALE, I.P. No.63049 
 Anterior Maxillary Osteotomy 
  
PREOPERATIVE      POSTOPERATIVE 
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DISCUSSION 
 
This investigation demonstrated that induced hypotension anesthesia 
patients in our group did result in reduced blood loss (as measured by the 
three methods). 
1. Estimated blood loss by surgeon 
2. Estimated blood loss by anesthetist.' 
3. Fromme's   ordinal   scale   for    assessment   of   surgical  field                
and improved surgeon's assessment of the surgical field. 
 
  Kelly and Terry37 assessed intravascular volume changes in orofacial 
corrective changes using chromium-51, double tagged red blood cells and 
radioiodinated serum albumin for red blood cell volume and plasma volume, 
respectively and concluded that there was no correlation between the 
surgeons estimated of blood loss and either the isotope measured changes.  
Of the three techniques of estimated of blood loss used in one study, as one 
might suspect because a similar study was done by Precious D.L et al58 which 
showed that the surgeons estimated tended to lie towards the lower estimated 
when reviewing with the data of Kelly and Terry37. 
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One might question, the use and accuracy of the non-invasive blood 
pressure monitor (NIBP) for a study of this nature.  Certainly, the "gold 
standard" of blood pressure measurement is an intra-arterial catheter 
transducer system.  These are however, not without risk.  The accuracy of 
automatic non-invasive blood pressure monitors has been questioned.  The 
unit used in our study was Hewlett Packard M3046A monitor cycling every 
10 minutes.  In our study, blood pressure was lowered to a level significantly 
different from that of the control group. 
 
The Fromme's ordinal scale was used as a tool of "surgical field 
assessment" in a reasonable attempt to objectively standardize this difficult to 
assess subjective parameter. 
 
We could foresee some potential bias, dependent on the difficulty of 
surgery, included in each group despite the effort to block and stratify the 
surgical cases. 
 
Contraindications to the use of induced hypotension anesthesia often 
relate to preexisting organ perfusion and oxygen delivery, but these problems 
are not typically or routinely found in our study population. 
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Thompson et al75 demonstrated that there was no difference in organ 
function indices between a control group and an induced hypotensive group 
during total hip arthroplasty, our study also did not lead to any organ 
dysfunction in either of the groups postoperatively. 
McNulty et al48 showed no adverse clinical  sequelae after induced 
hypotensive anesthesia using labetolol in 10 orthoganthic surgery patients.  
Similarly, no significantly complications were sited in our study using various 
methods of induced hypotensive anesthesia i.e., nitroglycerine, esmolol and 
halothane. 
In our study 6 orthognathic surgery patients were studied to compare 
blood loss, surgical field quality and procedure duration with and without 
induced hypotension anesthesia.  Precious et al 58, in a similar study showed 
that induced hypotension anesthesia reduced blood loss, and improved the 
surgical field, but did not significantly shorten the procedure.  Our study 
revealed that induced hypotensive anesthesia, resulted in reduced blood loss 
and improvement in surgical field which was similar to Precious et al 58 but the 
time of surgical procedure showed a statistical difference between the two 
groups and the mean time of surgery in the induced hypotension anesthesia 
group was less when compared to the normotensive control group.  This could 
be due to less surgical field and better visualization to work faster. 
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SUMMARY 
SUMMARY 
 
 A study was concluded on 6 patients undergoing osteotomy    
procedures for facial correction.  The study population consisted of two 
groups.  One group of 3 patients (normotensive anesthesia group) and the other 
group of 3 patients  (hypotension anesthesia group),  a comparative study on 
blood loss intra-operatively in these two groups were studied by assessing and 
comparing the blood loss estimated by the surgeon, anesthetist and surgical 
field. 
 
 The drugs used for anesthesia for the normotensive   groups were nitrous 
oxide and halothane and for the hypotensive group the addition of 
nitroglycerine and esmolol.  Blood loss was evaluated by the surgeon, 
anesthetist and according to Fromme's scale of surgical grading at intervals of 
15 minutes from the onset of procedure to the end of the procedure. 
 
 Our study showed that there is a significant difference between the 
blood loss in both the groups, and induced hypotension anesthesia group 
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showed reduced blood loss as assessed by the surgeon, anesthetist and 
according to Fromme's scale.  There was neither any organ dysfunction due to 
tissue hypoxia in any one of the subjects nor any complications. 
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CONCLUSION 
 
 Technique for minimizing blood loss are important for reducing the 
need for transfusion and the potential risk of a transfusion reaction or the 
transmission of blood borne pathogens.  This is especially relevant  when 
considering the elective nature of orthognathic surgery.  Induced hypotensive 
anesthesia is a useful and safe technique in the orthognathic population when 
properly applied and executed. 
 
 Further well-designed, prospective investigations are needed to define, 
which agents are most efficient and safe; the recommended parameters of 
induced hypotensive anesthesia with respect to blood pressure reduction; and 
effect on blood loss using most accurately available qualifying technique. 
 
 Induced hypotension anesthesia not only reduced the blood loss, but also 
provides a blood loss field helping the surgeon to work more effectively and 
minimize the time of surgery. 
 
 Hence, induced hypotensive anesthesia should routinely be applied 
especially in elective surgeries like orthognathic surgeries, which is of high 
beneficial value. 
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